CIPLA FDA Approval ANDA 078800

ANDA 078800

CIPLA

FDA Drug Application

Application #078800

Documents

Letter2009-05-06

Application Sponsors

ANDA 078800CIPLA

Marketing Status

Prescription001

Application Products

001TABLET;ORAL300MG0TENOFOVIR DISOPROXIL FUMARATETENOFOVIR DISOPROXIL FUMARATE

FDA Submissions

ORIG1AP2018-01-26
UNKNOWN; ORIG2AP2018-01-26STANDARD
LABELING; LabelingSUPPL17AP2019-11-19STANDARD
LABELING; LabelingSUPPL18AP2019-11-19STANDARD
LABELING; LabelingSUPPL19AP2019-11-19STANDARD
LABELING; LabelingSUPPL20AP2019-11-19STANDARD

Submissions Property Types

ORIG1Null1
SUPPL17Null7
SUPPL18Null15
SUPPL19Null15
SUPPL20Null7

TE Codes

001PrescriptionAB

CDER Filings

CIPLA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 78800
            [companyName] => CIPLA
            [docInserts] => ["",""]
            [products] => [{"drugName":"TENOFOVIR DISOPROXIL FUMARATE","activeIngredients":"TENOFOVIR DISOPROXIL FUMARATE","strength":"300MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"TENOFOVIR DISOPROXIL FUMARATE","submission":"TENOFOVIR DISOPROXIL FUMARATE","actionType":"300MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.